RST-SANEXAS

What RST-SANEXAS does

RST-SANEXAS is a privately held medical device manufacturer headquartered in Henderson, Nevada, that designs and produces the neoGEN® series of Electric Cell-Signaling Therapy (EcST) systems for healthcare providers. The company's proprietary technology delivers Electric cell-Signaling energy waves through AC current asymmetrical biphasic sine waves using patented Frequency Hopping Spread Spectrum (FHSS), with a portfolio described in quantum-based harmonic frequency terms. The neoGEN product family includes the flagship neoGEN System, the compact neoGEN Basic, and the physical therapy-focused neoGEN PT, all FDA-cleared for indications spanning post-traumatic and post-surgical pain, chronic intractable pain, muscle spasm relaxation, neuromuscular reeducation, disuse atrophy prevention, range of motion improvement, and local circulation enhancement. Complementary offerings include the SynRG Lights Series (red/infrared light therapy) and a line of after-care topical analgesics, supported by an extensive accessories catalog of electrodes, conductive sponges, cables, and training materials.

The business model is built on direct enterprise sales of capital equipment to pain management clinics, physical therapy practices, and chiropractic offices, with quote-based pricing, available financing, staff training, and a structured EcST Certification program to support provider adoption. A separate e-commerce storefront sells consumables and accessories globally, and an Affiliates program offers Distributorships, Vendor Affiliates, and Contract Manufacturing as additional channels. The customer base consists primarily of independent healthcare providers seeking non-pharmaceutical, non-opioid alternatives for chronic pain and neuromuscular rehabilitation. RST-SANEXAS has operated since 1994, accumulating more than 30 years of R&D and clinical testing, and currently operates with a stated headcount of 1–10 employees.

Name

RST-SANEXAS

Legal name

RST-SANEXAS

Website

https://rstsanexas.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

11–50 employees

Short description

RST-SANEXAS is a Henderson, Nevada-based medical device manufacturer that sells FDA-cleared neoGEN® Electric Cell-Signaling Therapy (EcST) systems to pain management clinics, physical therapy practices, and chiropractic offices for non-opioid pain and neuromuscular rehabilitation, supported by accessories and consumables.

Ownership category

akta.pro rank

Product category

Pain Management Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)

akta.pro secondary industry

OTC Pain Relief & Fever (Analgesics, Anti-inflammatory, Topical Pain Relief) (CRADAMAC)

Keywords

• Electric cell-signaling therapy
• Pain management devices
• Neuromuscular rehabilitation
• Medical device manufacturing
• Bioelectric therapy systems

Headquarters

HQ city

Las Vegas

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Technology or R&D, Personnel, Marketing or Sales, Supply Chain

Revenue model

1. Medical Device Sales: Sale of neoGEN Series medical devices (neoGEN System, neoGEN Basic, neoGEN PT) along with accessories including electrodes, sponges, cables, and consumables. Products are sold through direct enterprise sales with financing options available.
2. After Care Products: Sale of topical analgesics, supplements, and other after-care products to support ongoing patient treatment

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

RST-SANEXAS designs, manufactures, and sells FDA-cleared Electric Cell-Signaling Therapy (EcST) medical devices under the neoGEN brand for pain management, circulation improvement, and neuromuscular rehabilitation. The company sells the neoGEN System, neoGEN Basic, and neoGEN PT variants primarily through direct enterprise sales to pain management clinics, physical therapy practices, and chiropractic offices, supplemented by an e-commerce storefront for accessories and after-care topical products.

Product overview

RST-SANEXAS offers a comprehensive medical device portfolio centered on Electric Cell-Signaling Therapy (EcST) technology. The core offering consists of three neoGEN device variants: the flagship neoGEN System (full-featured Electric cell-Signaling device for pain management, rehabilitation, and neuromuscular treatment), the neoGEN Basic (compact, mobile, versatile version), and the neoGEN PT (physical therapy-focused variant). These FDA-cleared devices deliver therapeutic electrical energy through advanced AC current asymmetrical biphasic sine waves with patented Frequency Hopping Spread Spectrum (FHSS) technology. The product ecosystem includes the SynRG Lights Series for red/infrared light therapy, after-care topical analgesics, and an extensive accessories line covering electrodes (adhesive, carbon, specialty, vacuum cup), conductive sponges, cables, leads, fixation wraps, and training materials. The company serves healthcare providers including chiropractors, pain management practitioners, and physical therapists with both equipment and continuing education programs.

Differentiator

Problem solved

Functional benefit

Brands

• neoGEN®: Electric Cell-Signaling medical device system for pain management, rehabilitation, and neuromuscular treatment. FDA-cleared for multiple clinical indications.
• SynRG Lights Series

Products and services

• neoGEN® System

Quantifiable outcome

• 60% nerve pain reduction in CRPS patient within 2 weeks of 8-week program
• +2 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators1 record

Recent moves3 records

Expansion highlights5 records

Direct peers

• BTL Group: Global medical device company producing electrotherapy, shockwave, and laser therapy devices for pain management, rehabilitation, and aesthetics — directly overlapping with neoGEN's indications and customer base.
• Richmar (Compass Health Brands): Manufacturer of TENS/EMS units, ultrasound, and shortwave diathermy devices used by chiropractors, PTs, and pain clinics — a directly comparable electrotherapy competitor to the neoGEN system.
• Current Solutions (CMT): Provider of electrotherapy, ultrasound, and combination therapy devices targeting physical therapy and pain management markets — closely aligned with RST-SANEXAS's clinical positioning and GTM motion.
• Mettler Electronics: Long-established manufacturer of electrotherapy and ultrasound devices for physical therapy, pain management, and rehabilitation — directly overlapping with RST-SANEXAS's neoGEN product line in technology, customer base, and use cases.
• NeuroMetrix: Developer of wearable neurostimulation devices (Quell) for chronic pain — a focused direct peer in non-opioid, electrotherapy-based pain management with similar clinical indications.
• RS Medical (now part of Compass Health Brands): Specialist in TENS, EMS, and interferential pain management devices for clinicians and patients — overlapping technology stack, distribution channels, and customer segments with RST-SANEXAS.
• BioMedical Life Systems: Manufacturer of TENS, EMS, and interferential stimulators for rehabilitation and pain management, serving similar provider segments (PTs, chiropractors, pain clinics) as RST-SANEXAS.
• Zynex Medical: Public medical device company focused on non-opioid pain management through electrotherapy (NeuroMove, TENS/EMS) and patient monitoring — directly comparable product category and clinical positioning.

Broad incumbents

• Enovis (DJO/Chattanooga): Large orthopedic and rehabilitation medical device company whose Chattanooga division offers an extensive electrotherapy, TENS, and rehab equipment portfolio — a much larger incumbent competing in the same provider channels as RST-SANEXAS.

Emerging players

• Everyway Medical Instruments: Manufacturer and distributor of TENS/EMS, ultrasound, and physical therapy equipment serving smaller clinics and chiropractors — comparable in customer profile to RST-SANEXAS but with broader equipment portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RST-SANEXAS